Schizoaffective Disorders Terminated Phase 2 Trials for Memantine (DB01043)

Also known as: Schizoaffective disorder / Schizophrenia schizoaffective / Schizoaffective psychosis / Schizo-affective type schizophrenia

IndicationStatusPhase
DBCOND0033299 (Schizoaffective Disorders)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02234752Galantamine and Memantine Combination for Cognitive Impairments in SchizophreniaTreatment